Empirico
Emma Brandt, Ph.D. is a Senior Scientist-Drug Discovery at Empirico Inc. Emma has previous experience as an Independent Consultant at Vascugen and as a Research Associate at the University of Wisconsin-Madison. Emma's academic background includes a Ph.D. in Molecular Pharmacology and Experimental Therapeutics from Mayo Clinic Graduate School of Biomedical Sciences and a Bachelor of Science in Biomedical Sciences from the University of Wisconsin-River Falls.
This person is not in the org chart
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.